cardiology careers collections past issues search home
     

J Am Coll Cardiol, 1999; 34:2148-2149
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fauchier, L.
Right arrow Articles by Babuty, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fauchier, L.
Right arrow Articles by Babuty, D.

LETTERS TO THE EDITOR

Reply

Laurent Fauchier, MDa and Dominique Babuty, MD, PhDa

a Service de Cardiologie B, Centre Hospitalier Universitaire Trousseau, 37044 Tours, France

lfau{at}med.univ-tours.fr


We welcome the opportunity to respond to the letter from Dr. Stein regarding our article (1). Most of the considerations of this letter are related to Table 3 in our study. These data were only provided for general information about the patients with sudden death and those with arrhythmic events or free of events. Because the duration of follow-up is not taken into account, definitive conclusion based on these data would certainly be inadequate. Some of these patients may have low HRV, and may therefore be considered to have a poor prognosis, but were free of events because of a very short follow-up, as shown by the large standard deviation of the duration of follow-up in this group (53 ± 41 months). Therefore, analysis of variance was not performed on these data. Moreover, we do not consider that rmsSD is really higher in patients with sudden death (29 ± 12 ms) as compared with patients free of events (25 ± 15 ms), and it is exactly similar in patients with arrhythmic events (25 ± 8 ms). The nonparametric Mann-Whitney U test on these data was also inadequate, but found a nonsignificant p value when comparing rmsSD between each group (p = 0.4 to 0.9), because the difference is low as compared with the standard deviation of this variable.

It may be surprising that SDA5 was superior to SDNN in patients with outcomes. However, from a mathematic point of view, it is certainly not impossible to see segments with a standard deviation of their means superior to the standard deviation of the overall series, particularly when the number of normal to normal intervals is different in each segment, whether the heart rate is different or after exclusion of ectopic beats or artifact. Table 1 gives a simplified numeric example for confirmation.


View this table:
[in this window]
[in a new window]
 
Table 1 Three Segments of NN Intervals (in ms) of the Same Duration (10,000 ms) with a Standard Deviation of the Means of Each Segment Greater Than Standard Deviation of All NN Intervals

 
Dr. Stein pertinently noticed that VLF was relatively low in each group. Data were log-transformed after reviewing in the last version of the article to achieve normal distribution. Calculation was performed on the data in ms instead of ms2 for VLF, and we apologize for this mistake. In fact, VLF was 6.9 ± 1.1 ln ms2 in patients free of events, 6.1 ± 1.5 ln ms2 in patients with sudden death and 6.6 ± 1.3 ln ms2 in patients with arrhythmic events; therefore, VLF was greater than LF and HF in each group. The ratio of VLF to total power was calculated on data in ms2 before the log transformation, as in the report of Mortara et al. (2).

Several complex phenomena may indeed participate to HRV in clinical practice, in particular, in patients with congestive heart failure. We would be happy to collaborate with Dr. Stein to study "erratic sinus rhythm" with a specific research software, because the analogic tape of the ambulatory electrocardiograms of our patients is still available. However, from a practical standpoint, we consider that an important issue of our article is that our results were obtained with a commercially available Holter monitoring system, and with demonstration that SDNN, a simple and reproducible measurement of HRV, is probably the most powerful for risk stratification. These findings may have more direct implications for identifying patients at risk and may guide subsequent investigations and therapy, either on an individual basis or as part of a controlled clinical trial.


    References
 Top
 References
 

  1. Fauchier L, Babuty D, Cosnay P, Fauchier JP. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1999;33:1203–1207[Abstract/Free Full Text]
  2. Mortara A, Sleight P, Pinna GD, et al. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. Circulation. 1997;96:246–252[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fauchier, L.
Right arrow Articles by Babuty, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fauchier, L.
Right arrow Articles by Babuty, D.

 
  cardiology careers collections past issues search home